Although m6A levels were not directly measured, these findings raise the possibility that TEAD1–YAP signaling may intersect with the METTL3/METTL14 m6A machinery to coordinate mitochondrial and inflammatory gene expression in AKI. The gene discussed is TEAD1; the disease is acute kidney injury.